Sanctuary Wealth Management’s First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF LMBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$11.6K Hold
238
0.01% 165
2024
Q3
$11.8K Hold
238
0.01% 170
2024
Q2
$11.4K Hold
238
0.01% 150
2024
Q1
$11.5K Hold
238
0.01% 146
2023
Q4
$11.5K Hold
238
0.01% 142
2023
Q3
$11.2K Hold
238
0.01% 125
2023
Q2
$11.3K Buy
+238
New +$11.4K 0.01% 133

Other funds holding LMBS

Sanctuary Wealth Management's LMBS Position: Q4 2024 in Review

Sanctuary Wealth Management held its First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF (LMBS) position steady in Q4 2024 at 238 shares worth $11.6K. The position accounts for 0.01% of the portfolio, ranked #165.

Sanctuary Wealth Management first reported a position in LMBS in Q2 2023 and has held it in 7 quarters since. The position peaked at $11.8K in Q3 2024. 413 funds tracked by Wall St. Rank hold LMBS as of Q4 2024.

  • Sanctuary Wealth Management held 238 shares of First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF worth $11.6K as of Q4 2024.
  • Sanctuary Wealth Management left its First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF share count unchanged in Q4 2024.
  • First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF made up 0.01% of Sanctuary Wealth Management's portfolio in Q4 2024, its #165 holding.
  • Sanctuary Wealth Management first reported a position in First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF in Q2 2023 and has held it in 7 quarters since.
  • Sanctuary Wealth Management's First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF position peaked at $11.8K in Q3 2024.
  • 413 funds tracked by Wall St. Rank held First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF as of Q4 2024.

Based on Sanctuary Wealth Management's 13F filing for Q4 2024, filed 12 Feb 2025.